HMS TransMed Program

HMS TransMed: Identifying Unmet Medical Needs and Translational Solutions

PROGRAM SCOPE

In this course, students will investigate how unmet medical needs are identified, follow the discovery process that uncovers the causes of disease, and examine the practice of effective disease detection, diagnosis, and treatment. The course will feature assessments of unmet medical needs, case studies of successes and failures in translation, seminars from translational experts, and workshops that engage students in substantive and intensive discussions on current topics.  An optional component of the course will have students travel to Durban, South Africa, the center of the HIV epidemic to understand unmet needs in a resource-poor setting and devise potential solutions.

The deep understanding of translational medicine imparted by the HMS TransMed course will endow students with the requisite lens through which to identify the unmet medical needs of patients and engage in the creation of novel interventions.

PROGRAM MISSION

To engage future biomedical research leaders in the practice of translational medicine.

AUDIENCE

This program is expected to serve MD, MD/PhD, and PhD students from Harvard Medical School, Harvard University, and MIT, and MD students and fellows from other US and international institutions. Enrollment will be limited to 30 students.

COURSE SCHEDULE

Required:
June 13 - 24, 2016
Two weeks of intensive class work at Harvard Medical School

Optional:
June 25 - July 1, 2016
One week of field work in Durban, South Africa, Hosted by the HIV Pathogenesis Programme

HMS TransMed Faculty of Interest

Faculty Director  
Jagesh Shah, PhD HMS/BWH
 
Global Component Co-Director
Filippos Porichis, PhD The Ragon Institute
 
Course Faculty  
Catherine Dubreuil, PhD HMS
 
Participating Faculty (for complete list see Faculty tab) 
Academic
Tim Mitchison, PhD, HMS/HiTS
Daniel DeAngelo, MD, DFCI
Paul Ridker, MD, BWH
Mark Trusheim, PhD, MIT/Sloan
Peter Sorger, PhD
Jerry Avorn, MD HMS/HiTS, BWH
 
Industry
Oxana Beskrovnaya, PhD, Genzyme/Sanofi
Ann Kwong, PhD, InnovaTID
Edward Garmey, MD, Cerulean Pharma, Inc.
Kimberley Stickland, PhD, DABT, Epizyme
Mark Goldberg, MD, Synageva
Sanyal Subhabrata, PhD Biogen IDEC